Head and Neck Cancer (H&N)NCT07426874
eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors
A study testing eHealth Survivorship Support Tool in people with Head and Neck Cancer (H&N), run by Royal College of Surgeons, Ireland at 1 site in Ireland.
Trial summary
This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Head and Neck Cancer (H&N)
- What is being tested?
- eHealth Survivorship Support Tool
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteIreland
- Study dates
- 1 Sep 2025to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent
Who cannot join
- Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)
Trial locations and contacts
1 site in 1 country.
About this study
This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.
Read the detailed description
Head and neck cancer (HNC) survivors experience significant long-term physical, functional, and psychosocial sequelae including dysphagia, speech impairment, fatigue, pain, and psychological distress. Traditional follow-up models rely on periodic clinic visits and may not adequately support self-management.
This study involves three phases:
Development of a co-designed eHealth support platform.
Implementation of the intervention within survivorship care pathways.
Evaluation of clinical effectiveness using patient-reported outcomes and healthcare utilization metrics.
The intervention integrates:
Symptom tracking Educational resources Self-management tools Structured nurse-guided follow-up
The primary hypothesis is that structured digital survivorship support will improve global quality of life compared to usual follow-up care.
- Conditions
- Head and Neck Cancer (H&N)
- Being tested
- eHealth Survivorship Support Tool, Control
- Keywords
- Head and Neck Cancer
- Medical subject headings
- Head and Neck Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
eHealth Survivorship Support ToolOther
A digital platform including:
Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up
ControlOther
Standard follow up
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Intervention Name: eHealth Survivorship Support Tool
Description:
A digital platform including:
Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up Receives: Other: eHealth Survivorship Support Tool |
| Control | Active comparator | Participants receive standard survivorship follow-up as per institutional guidelines. Receives: Other: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Life EORTC QLQ-C30 (Global Health Status scale)
Measurement Tool: EORTC QLQ-C30 (Global Health Status scale) Time Frame: Baseline, 3 months, 6 months
Measured: Baseline, 3 months, 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Feb 2026
- Study start1 Sep 2025
- Primary completion12 Oct 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Head and Neck Cancer (H&N)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Royal College of Surgeons, Ireland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07426874
- Sponsor's protocol ID
- BH-REC-eHealth-2026
- Status last verified
- Feb 2026
- First submitted
- 16 Feb 2026
- Last updated
- 23 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 23 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors
- ClinicalTrials.gov ID
- NCT07426874
- Acronym / sponsor ID
- BH-REC-eHealth-2026
- Conditions
- Head and Neck Cancer (H&N)
- Keywords
- Head and Neck Cancer
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Royal College of Surgeons, IrelandUniversity, hospital or other
- Study start
- 1 Sep 2025 (actual)
- Primary completion
- 12 Oct 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 23 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.
Detailed description
Head and neck cancer (HNC) survivors experience significant long-term physical, functional, and psychosocial sequelae including dysphagia, speech impairment, fatigue, pain, and psychological distress. Traditional follow-up models rely on periodic clinic visits and may not adequately support self-management.
This study involves three phases:
Development of a co-designed eHealth support platform.
Implementation of the intervention within survivorship care pathways.
Evaluation of clinical effectiveness using patient-reported outcomes and healthcare utilization metrics.
The intervention integrates:
Symptom tracking Educational resources Self-management tools Structured nurse-guided follow-up
The primary hypothesis is that structured digital survivorship support will improve global quality of life compared to usual follow-up care.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: eHealth Survivorship Support ToolIntervention Name: eHealth Survivorship Support Tool Description: A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up |
| Control | Active comparator | Other: ControlParticipants receive standard survivorship follow-up as per institutional guidelines. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent
Key exclusion criteria (1 listed)
- Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| eHealth Survivorship Support ToolA digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up | Other | Intervention |
| ControlStandard follow up | Other | Control |
Primary outcome
Quality of Life EORTC QLQ-C30 (Global Health Status scale)
Time frame: Baseline, 3 months, 6 months
Measurement Tool: EORTC QLQ-C30 (Global Health Status scale) Time Frame: Baseline, 3 months, 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Head and Neck Cancer (H&N)
RecruitingPhase 4
Lidocaine Infiltration and Neuroimmunomodulation in Head and Neck Cancer Surgery
Head and Neck Cancer (H&N)
Enrolling by invitationObservational study
Head and Neck Cancer Strategies
Head and Neck Cancer (H&N), Thyroid Cancer
RecruitingPhase 1/2
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
Solid Tumor, NSCLC
Not yet recruiting
Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy
Head and Neck Cancer (H&N), Oral Mucositis (Ulcerative) Due to Radiation
Recruiting
Swallowing Rehabilitation Program for Head and Neck Tumor Patients
Head and Neck Cancer (H&N)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing eHealth Survivorship Support Tool in people with Head and Neck Cancer (H&N), run by Royal College of Surgeons, Ireland at 1 site in Ireland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Life EORTC QLQ-C30 (Global Health Status scale) (time frame: Baseline, 3 months, 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.